ADHD Medication Did Not Improve Long-Term School Grades in a Large Norwegian Study
Evidence review & editorial synthesis
ADHD medication can make it easier to concentrate, control impulses and stay on a task. It therefore seems intuitive that years of treatment should also produce better school grades.
A large Norwegian study challenges that assumption.
Researchers followed 6,255 children and adolescents diagnosed with ADHD and examined medication treatment from diagnosis through the end of compulsory schooling. Using a statistical strategy designed to get closer to causality than an ordinary observational comparison, they found no detectable effect of medication on final grades.
That does not mean the drugs provide no cognitive benefit. Instead, it exposes an important gap between improving attention and improving long-term academic achievement.
No detectable improvement in final grades
The study included Norwegian children aged 5 to 15 who received an ADHD diagnosis between 2009 and 2011. Researchers linked national registry information on medication prescriptions with final tenth-grade outcomes.
They examined grade point average, grades in nine major subjects and whether students lacked a basis for assessment.
A conventional regression initially produced the result many people would expect: greater medication treatment was associated with a slightly higher grade point average. The difference was small, about 0.05 points on a grade scale whose standard deviation was 0.94.
But observational comparisons can be misleading. Children who receive more consistent treatment may differ from other children in family support, healthcare access, symptom severity and many other ways.
The researchers therefore used differences in treatment practices as an instrumental variable to estimate what medication itself was doing among children near the margin of treatment.
That analysis found no detectable causal benefit. The estimated effect on grade point average was essentially zero, and there was no effect on individual subjects or lack of assessment.
The confidence interval around the main estimate was wide, so this should not be interpreted as proof that medication can never affect grades. It also applies most directly to children whose probability of receiving treatment changed with prescribing practices.
Yet ADHD medication can improve cognition
The finding raises an obvious question. If medication does not improve long-term grades, does it actually improve thinking?
Evidence from controlled studies says that it can.
A 2024 meta-analysis examined longer-term medication effects on executive functions. Across 18 studies and 1,667 participants, methylphenidate improved attention, inhibition, reaction time and working memory compared with placebo. Effect sizes were generally small to moderate.
This distinction matters. Better grades and better cognitive performance are not the same outcome.
Medication can make someone more capable of sustaining attention, resisting distractions or holding information in working memory without necessarily erasing years of accumulated academic difficulty.
Nor is cognitive improvement equivalent to becoming more intelligent. The better description is that medication can improve some of the mental processes that ADHD disrupts.
Students often do more work, but the gains are smaller than expected
The same pattern appears inside classrooms.
A meta-analysis covering 43 studies and 2,110 children found that ADHD medication increased time spent on task by as much as about 14% and the amount of schoolwork completed by as much as 15%.
A separate review of methylphenidate found that treated students completed 7.8% more mathematics work and improved math accuracy by about 3%. Reading speed improved, while reading accuracy did not significantly change.
The authors reached an important conclusion: academic improvements were much smaller than improvements in ADHD symptoms.
That helps explain how both things can be true. A child may sit through more of a lesson, complete more exercises and become less distractible while still ending the year with similar final grades.
Grades depend on much more than what happens to attention during today's lesson. They reflect accumulated knowledge, attendance, study habits, organization, motivation, teaching quality, learning disorders, home environment, sleep and years of previous education.
Medication can improve access to learning. It cannot automatically supply what was missed before treatment began.
Better focus is not the same as better life outcomes
The Norwegian finding is also not the final word on education.
Earlier Swedish registry research involving more than 650,000 students found ADHD medication associated with higher school grades and a greater likelihood of qualifying for upper secondary education. Another within-person study found higher university entrance-test scores during periods when people with ADHD were medicated.
Those studies used different methods and cannot eliminate every source of confounding. The new Norwegian analysis was designed specifically to address some of that problem, which may help explain why its result was less positive.
The larger lesson is that treatment goals should not collapse into a single number on a report card.
Medication may reduce ADHD symptoms and improve attention, inhibition and immediate classroom productivity while leaving long-term academic achievement largely unchanged for some students.
If better grades are the goal, medication may therefore be only one part of the solution. Effective treatment can create a better opportunity to learn. Educational support, study strategies, accommodations and targeted help with accumulated learning gaps may still determine whether that opportunity becomes lasting academic progress.
Scientific References & Further Reading
- Anchor Study: “Effect of pharmacological treatment of attention-deficit hyperactivity disorder on academic performance: registry-based population study.” (Lyhmann I, Widding-Havneraas T, Markussen S, et al. British Journal of Psychiatry. 2026. doi:10.1192/bjp.2026.10754.)
- Cognitive Effects Meta-Analysis: “The effects of chronic administration of stimulant and non-stimulant medications on executive functions in ADHD: A systematic review and meta-analysis.” (Isfandnia F, El Masri S, Radua J, Rubia K. Neurosci Biobehav Rev. 2024;162:105703. doi:10.1016/j.neubiorev.2024.105703.)
- Classroom Effects Meta-Analysis: “How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom?.” (Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K. Eur Child Adolesc Psychiatry. 2013;22:203-216. doi:10.1007/s00787-012-0346-x.)
- Academic Performance Meta-Analysis: “Does methylphenidate improve academic performance? A systematic review and meta-analysis.” (Kortekaas-Rijlaarsdam AF, Luman M, Sonuga-Barke E, Oosterlaan J. Eur Child Adolesc Psychiatry. 2019;28:155-164. doi:10.1007/s00787-018-1106-3.)
- Swedish School Performance Study: “Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication.” (Jangmo A, Stalhandske A, Chang Z, et al. J Am Acad Child Adolesc Psychiatry. 2019;58:423-432. doi:10.1016/j.jaac.2018.11.014.)
- Entrance Test Study: “Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder.” (Lu Y, Sjolander A, Cederlof M, et al. JAMA Psychiatry. 2017;74:815-822. doi:10.1001/jamapsychiatry.2017.1472.)
Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not a substitute for diagnosis, treatment, or individualized medical care.

